<?xml version="1.0" encoding="UTF-8"?>
<p>In 2009, Keyaerts 
 <italic>et al.</italic> further investigated both the 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> antiviral activities of CQ against human CoV strain OC43 (HCoV-OC43) in newborn mice.
 <sup>
  <xref rid="bibr29-2049936120947517" ref-type="bibr">29</xref>
 </sup> They concluded that CQ interferes with the 
 <italic>in vitro</italic> replication of HCoV-OC43, and showed 100% survival in newborn mice treated pre-partum with CQ. Their result showed that CQ could be immensely useful against HCoV-OC43.
</p>
